Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development of Novel Isatin-Tethered Quinolines as Anti-Tubercular Agents against Multi and Extensively Drug-Resistant Mycobacterium tuberculosis
Mohamed A. Abdelrahman, Hadia Almahli, Tarfah Al‐Warhi, et al.
Molecules (2022) Vol. 27, Iss. 24, pp. 8807-8807
Open Access | Times Cited: 17

Showing 17 citing articles:

Discovery of sulfonamide-tethered isatin derivatives as novel anticancer agents and VEGFR-2 inhibitors
Moataz A. Shaldam, Hadia Almahli, Andrea Angeli, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 27
Identification of new anti-mycobacterial agents based on quinoline-isatin hybrids targeting enoyl acyl carrier protein reductase (InhA)
Eman F. Khaleel, Ahmed Sabt, Małgorzata Korycka-Machała, et al.
Bioorganic Chemistry (2024) Vol. 144, pp. 107138-107138
Closed Access | Times Cited: 9
Identification of dual-target isoxazolidine-isatin hybrids with antidiabetic potential: Design, synthesis, in vitro and multiscale molecular modeling approaches
Siwar Ghannay, Budur Saleh Aldhafeeri, Iqrar Ahmad, et al.
Heliyon (2024) Vol. 10, Iss. 4, pp. e25911-e25911
Open Access | Times Cited: 6
QSAR Study on Potent Derivatives with Anti-TB Activity: A Review
Payal Lahusham Savalkar
(2025) Vol. 7, Iss. 1, pp. 1-12
Open Access
Quinoline analogs: multifaceted heterocyclic compounds with varied synthetic strategies and potent antitubercular properties
Rajendra Prasad Pakhariya, Ayushi Bhatnagar, Gangotri Pemawat
RSC Advances (2025) Vol. 15, Iss. 5, pp. 3646-3663
Open Access
Identification of 2-(N-aryl-1,2,3-triazol-4-yl) quinoline derivatives as antitubercular agents endowed with InhA inhibitory activity
Ahmed Sabt, Maha-Hamadien Abdulla, Manal S. Ebaid, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 4
Identification of sulphonamide-tethered N -((triazol-4-yl)methyl)isatin derivatives as inhibitors of SARS-CoV-2 main protease
Mai H. ElNaggar, Abdullah A. Elgazar, Ghada Gamal, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 13
Comprehensive coverage on anti-mycobacterial endeavour reported during 2022
Tejas M. Dhameliya, Drashtiben D. Vekariya, Heta Y. Patel, et al.
European Journal of Medicinal Chemistry (2023) Vol. 255, pp. 115409-115409
Closed Access | Times Cited: 11
Discovery of new quinoline derivatives bearing 1-aryl-1,2,3-triazole motif as influenza H1N1 virus neuraminidase inhibitors
Ahmed Sabt, Eman F. Khaleel, Moataz A. Shaldam, et al.
Bioorganic Chemistry (2024) Vol. 151, pp. 107703-107703
Closed Access | Times Cited: 2
Quinoline Derivatives as Promising Scaffolds for Antitubercular Activity: A Comprehensive Review
Mohammad Owais, Arun Kumar, S. S. Hasan, et al.
Mini-Reviews in Medicinal Chemistry (2024) Vol. 24, Iss. 13, pp. 1238-1251
Closed Access | Times Cited: 1
1-(2-(3,5-Di-tert-butyl-4-hydroxyphenyl)-2-oxoethyl) Quinolin-1-ium Bromide
Rusi I. Rusew, K. Iliev, Vanya B. Kurteva, et al.
Molbank (2024) Vol. 2024, Iss. 1, pp. M1763-M1763
Open Access | Times Cited: 1
Design, synthesis and molecular modeling of isatin-aminobenzoic acid hybrids as antibacterial and antibiofilm agents
Awwad A. Radwan, Fares K. Al-Anazi, Mohammed Al-Agamy, et al.
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 11, pp. 101781-101781
Open Access | Times Cited: 3
Isatin Derivatives: A Frontier in Antimicrobial Agents
Shareef Shaik, Manish Chaudhary, Charanjit Kaur, et al.
Letters in Organic Chemistry (2023) Vol. 21, Iss. 4, pp. 333-350
Closed Access | Times Cited: 3
Design and synthesis of benzo[b]thiophene‐based hybrids as novel antitubercular agents against MDR/XDR Mycobacterium tuberculosis
Tarfah Al‐Warhi, Nermeen M. Rashad, Hadia Almahli, et al.
Archiv der Pharmazie (2023) Vol. 357, Iss. 2
Closed Access | Times Cited: 3
Novel indolinone-tethered benzothiophenes as anti-tubercular agents against MDR/XDR M. tuberculosis: Design, synthesis, biological evaluation and in vivo pharmacokinetic study
Wagdy M. Eldehna, Sally Tarek Mahmoud, Esraa R. Elshnawey, et al.
Bioorganic Chemistry (2023) Vol. 143, pp. 107009-107009
Closed Access | Times Cited: 2
Quinoline hybrid derivatives as effective structural motifs in the treatment of tuberculosis: Emphasis on structure-activity relationships
V. S. Hegde, Raveendra Bhat, Srinivasa Budagumpi, et al.
Tuberculosis (2024) Vol. 149, pp. 102573-102573
Closed Access
Isoniazid Hybrids As Potential Antitubercular Agents
Sahil Mishra, Gobind Kumar, Parvesh Singh
ChemistrySelect (2024) Vol. 9, Iss. 38
Open Access
Page 1

Scroll to top